UnitedHealth Group Incorporated
UNH
Market Cap$254.96B
Volume16.43M
Revenue$410.06B
Gross Profits$90.17B
Employees400000
About
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers c...
AI Summary
| Model | Near-Term (0-3 mo.) | Mid-Term (3-12 mo.) | Long-Term (1-5 yr.) |
|---|---|---|---|
| Deepseek | Hold | Buy | Strong Buy |
| OpenAI | Buy | Buy | Strong Buy |
| Gemini | Hold | Buy | Buy |
| Grok | Buy | Hold | Buy |
Detailed Analysis
Deepseek
Holdnear term
Current price below 50-day average suggests short-term weakness, but valuation metrics are attractive.
Valuation:Undervalued based on forward PE and trailing PEG ratio.
Technical:Price below 50-day average indicates short-term bearish trend.
Sentiment:Low beta suggests less volatility, possibly muted short-term movements.
News:No significant recent news to drastically impact near-term price.
Buymid term
Attractive valuation and sector stability may drive recovery towards 200-day average.
Valuation:Forward PE and PEG ratio indicate room for growth.
Technical:Potential rebound towards 200-day average as mid-term trend corrects.
Sentiment:Healthcare sector's defensive nature may attract investors in uncertain markets.
News:Monitor for sector-specific news or company developments that could impact performance.
Strong Buylong term
Strong fundamentals and sector growth prospects support long-term appreciation.
Valuation:Significantly undervalued with strong earnings growth potential.
Technical:Long-term moving averages may provide support for upward trajectory.
Sentiment:Healthcare sector expected to benefit from demographic trends.
News:Innovation and expansion in healthcare services could drive long-term growth.
Gemini
Holdnear term
Negative technical indicators offset the undervaluation, suggesting caution in the short term.
Valuation:Forward P/E suggests undervaluation.
Technical:Price below 50 and 200-day averages indicates a downtrend.
Sentiment:Neutral sentiment due to conflicting valuation and technical signals.
News:No specific news impacting near-term outlook identified.
Buymid term
Undervaluation and growth potential suggest a buy, but monitor technicals.
Valuation:Low forward P/E and trailing PEG ratio indicate undervaluation.
Technical:Potential for price recovery towards 200-day average.
Sentiment:Positive sentiment expected with potential market recovery.
News:No specific news impacting mid-term outlook identified.
Buylong term
Strong market cap and undervaluation support long-term growth potential.
Valuation:Consistent undervaluation and growth prospects.
Technical:Potential for long-term uptrend given market leadership.
Sentiment:Positive long-term sentiment due to market dominance.
News:No specific news impacting long-term outlook identified.
Openai
Buynear term
Current price below average suggests a potential rebound in the short term.
Valuation:Low forward PE and favorable PEG ratio indicate undervaluation.
Technical:Price below both 50-day and 200-day averages, signaling potential buying opportunity.
Sentiment:Market sentiment may be cautious due to recent price drops.
News:No major negative news; sector remains stable.
Buymid term
Expect recovery and growth as market adjusts to company's fundamentals.
Valuation:Attractive valuation metrics compared to industry peers.
Technical:Potential for technical rebound as price approaches 200-day moving average.
Sentiment:Improving sentiment as healthcare sector gains more attention.
News:Positive outlook on healthcare innovations and expansions.
Strong Buylong term
Strong fundamentals and sector growth prospects support a robust long-term outlook.
Valuation:Consistently strong earnings growth supports long-term investment.
Technical:Historical performance and stability in stock suggest solid long-term growth.
Sentiment:Long-term positive sentiment driven by ongoing healthcare demand.
News:Strategic initiatives and market leadership likely to drive future growth.
Grok
Buynear term
Current price below moving averages suggests short-term recovery. Positive momentum expected.
Valuation:Forward P/E of 10.13 indicates potential undervaluation.
Technical:Price below 50-day average; potential for rebound.
Sentiment:Market sentiment appears neutral with cautious optimism.
News:No major negative news; stable outlook.
Holdmid term
Price significantly below 200-day average; uncertainty persists. Monitor for stabilization.
Valuation:Trailing PEG ratio of 0.807 suggests fair value.
Technical:Significant gap from 200-day average indicates caution.
Sentiment:Mixed sentiment due to broader healthcare sector challenges.
News:Potential regulatory or sector headwinds possible.
Buylong term
Strong fundamentals and low beta support long-term growth. Healthcare sector remains resilient.
Valuation:Attractive forward P/E supports long-term value.
Technical:Long-term trends likely to stabilize and recover.
Sentiment:Positive long-term outlook for healthcare industry.
News:Expected innovation and growth in healthcare services.